查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1438430

灭菌设备：市场占有率分析、产业趋势/统计、成长预测（2024-2029）

Global Sterilization Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2024年全球灭菌设备市场规模为89.4亿美元，预计2029年将达127.7亿美元，预测期（2024-2029年）复合年增长率为7.37%。

全球灭菌设备市场

COVID-19 大流行改变了医疗保健优先事项并对医疗保健管理产生了负面影响。疫情爆发之初，多个国家处于封锁状态。由于我们关闭与其他国家的贸易并实施旅行限制，包括治疗、诊断和手术在内的医疗服务在 2020 年上半年有所下降。预防医院感染对于 COVID-19 的临床管理非常重要。发表于 2021 年 8 月，题为「英国第一波 COVID-19 大流行浪潮中的医院获得性 SARS-CoV-2 感染」。研究显示，英国314 家医院中感染COVID-19 的患者中有11.3 % 受感染入学后。 2020 年 5 月，这一比例增至 15.8%。因此，这次疫情影响了医疗机构的医院感染控制能力，并显着增加了对灭菌器的需求。由于 COVID-19 病例的增加，政府组织也在努力减少 COVID-19 的影响。例如，根据美国食品药物管理局(USFDA) 2020 年 3 月的更新，为行业和食品药物管理局工作人员提供了指南，以促进无菌或消毒医疗设备的快速週转并提高COVID-19 期间在的安全性大流行期间，保持消毒器、消毒设备和空气清净机的供应是适当的，以帮助降低患者和医护人员因突发公共卫生事件而接触SARS-CoV-2病毒的风险。这就是我的意思。美国食品药物管理局认为，在这次公共卫生紧急情况下增加灭菌器、消毒剂和空气清净机的供应将有助于解决这些紧迫的公共卫生问题。

随着世界人口的增加，各种感染疾病的盛行率正在迅速增加。其中许多疾病需要医疗介入或手术。手术中使用的仪器和设备必须是无菌的。此外，受感染的设备还可能造成疾病的交叉感染。根据美国整形外科医师协会2020年全国整形外科统计数据，2020年美国进行了2,314,720例整容手术，2019年进行了2,678,302例手术。此外，2020 年和 2019 年美国进行的重组手术总数分别为 6,878,486 例和 6,652,591 例。由于这些手术需要无菌器械，预计未来几年市场将显着成长。

这些因素增加了对消毒设备的需求，以防止感染疾病的进一步传播。製药公司进入市场也是市场成长的主要因素。然而，这些设备的核准和製造的严格监管标准，以及某些设备中使用的化学消毒剂对眼睛和皮肤的潜在损害，已经减缓了市场的发展，抑制了成长。

灭菌设备市场趋势

高温灭菌器占据市场主导地位

高温装置是应用最广泛、最可靠的灭菌装置。高温灭菌通常对患者、工作人员和环境无害，并且能够非常有效地杀死细菌。它还具有成本效益，因为它能深入渗透到医疗设备中，并且与其他灭菌设备相比成本更低。这些因素促成了该细分市场的市场主导地位。高温灭菌器又细分为蒸气灭菌器和干式灭菌器。

几种外科手术的增加可能会促进该过程中使用的手术器械的高温灭菌，从而促进该细分市场的成长。根据美国关节置换登记处的 2020 年年度报告，2012 年至 2019 年间，美国进行了 1,897,050 例初次和重新置换髋关节和膝关节置换术。此外，2012 年至 2019 年间，美国进行了约 995,410 例全膝关节置换术和 625,097 例全髋关节置换术。

根据美国代谢和减肥外科学会的统计数据，2019 年仅美国就进行了约 256,000 例手术，2018 年为 252,000 例。这些统计数据显示减重手术数量的增加，推动了整体市场的成长。

此外，该领域新产品的推出可能会推动市场成长。例如，2020年5月，Esco推出了具有高温灭菌功能的Esco CelCulture CO2培养箱（CCL-HHS）。事实证明，这可以有效杀死可能污染工作空间的抗药性真菌、细菌孢子和植物细胞。因此，预计这些因素将在预测期内推动该行业的成长。

北美将经历最快的成长

北美灭菌设备市场出现了积极增长，预计在预测期内将出现显着增长。交叉污染和医院感染风险的增加、手术数量的增加、大型市场参与者的存在以及研发程序的增加预计将推动该地区的市场。预计美国将主导北美市场。

根据美国疾病管制与预防中心发布的 2020 年 HAI 进展报告执行摘要，美国大约每 31 名患者美国就有 1 人至少有一种院内感染，该国医疗机构的患者照护这凸显了改进实践的必要性。因此，该国的医院感染增加了对适当卫生维护和消毒的需求，包括及时更换医院窗帘。

此外，老年人更容易接受手术且免疫力较低，这使他们面临更高的感染疾病风险。根据《2019年世界老化报告》，预计该国老年人口将从2019年的5,334万增加到2050年的8,381.3万，这将增加感染疾病的发生率，并有助于市场成长。

该领域的技术进步也正在推动市场。例如，2020 年 9 月，Midmark Corporation 推出了新的灭菌器资料记录器和更新的 Midmark M3 蒸气灭菌器，为美国牙科诊所的器械处理带来了速度、简单性和合规性。

因此，对医疗设备和其他仪器的需求激增，增加了对灭菌设备的需求。

灭菌器产业概况

大多数灭菌设备是由世界各地的公司製造的。拥有更多研究经费和更好分销系统的市场领导已经确立了自己的市场地位。主要市场参与者包括 Getinge AB、Fortive Corporation、Anderson Products、Cantel Medical 和 Steris PLC。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动因素
    • 交叉感染的风险增加
    • 手术数量增加
    • 製药和生物技术产业的成长
  • 市场限制因素
    • 与设备相关的高成本
    • 接触设备中的化学品
  • 波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度

第五章市场区隔

  • 按设备
    • 高温灭菌
      • 湿/蒸气灭菌
      • 干燥灭菌
    • 低温灭菌
      • 环氧乙烷 (ETO)
      • 过氧化氢
      • 臭氧
      • 其他低温灭菌器
    • 过滤除菌
    • 放射线杀菌
      • 电子束灭菌
      • 伽玛射线灭菌
      • 其他电离放射线杀菌设备
  • 按最终用户
    • 医院和诊所
    • 製药和生物技术公司
    • 教育/研究机构
    • 食品和饮料业
    • 其他最终用户
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东/非洲
      • GCC
      • 南非
      • 其他中东和非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章 竞争形势

  • 公司简介
    • Fortive Corporation（Advanced Sterilization Products）
    • Anderson Products
    • Metall Zug Group（Belimed）
    • Cantel Medical
    • Getinge AB
    • Matachana Group
    • MMM Group
    • STERIS PLC
    • Systec GmbH
    • Stryker Corporation（TSO3 INC.）

第七章 市场机会及未来趋势

简介目录
Product Code: 66760

The Global Sterilization Equipment Market size is estimated at USD 8.94 billion in 2024, and is expected to reach USD 12.77 billion by 2029, growing at a CAGR of 7.37% during the forecast period (2024-2029).

Global Sterilization Equipment - Market

The COVID-19 pandemic has altered healthcare priorities, adversely impacting healthcare management. In the initial days of the pandemic, several countries were in lockdown. They suspended trade with other countries and implemented travel restrictions, leading to a decline in healthcare services such as treatments, diagnosis, and surgical procedures in the first half of 2020. Preventing hospital-acquired infections is a critical aspect of the clinical management of COVID-19, as hospital-acquired infections have been a common feature of such outbreaks. According to the study titled 'Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave', published in August 2021, 11.3% of patients with COVID-19 in 314 UK hospitals became infected after hospital admission. This rate increased to 15.8% in May 2020. Thus, the outbreak has impacted the healthcare facilities' ability to manage hospital-acquired infections, significantly increasing the demand for sterilizers. Due to the rising COVID-19 cases, government associations also worked toward reducing the COVID-19 impact. For instance, as per a March 2020 update by the US Food and Drug Administration (USFDA), Guidance for Industry and Food and Drug Administration Staff, it is adequate to maintain the supply of sterilizers, disinfectant devices, and air purifiers that can facilitate the rapid turnaround of sterilized or disinfected medical equipment and help reduce the risk of viral exposure for patients and healthcare providers to SARS-CoV-2 for public health emergency during the COVID-19 pandemic. The USFDA believes that the policy outlined will help address these urgent public health concerns by increasing the availability of sterilizers, disinfectant devices, and air purifiers during this public health emergency.

With the growing global population, the prevalence of various infectious diseases has rapidly increased. Many of these diseases require medical interventions and surgeries. The instruments and devices used in the surgeries need to be sterilized. Moreover, the infected instruments may give rise to the cross-transmission of diseases. According to the National Plastic Surgery Statistics 2020 by the American Society of Plastic Surgeons, 2,314720 cosmetic surgical procedures were performed in the United States in 2020, and 2,678,302 surgeries were performed in 2019. Additionally, the total number of reconstructive procedures performed in 2020 and 2019 were 6,878,486 and 6,652,591, respectively, in the United States. As these surgeries require sterilized instruments, the market is expected to witness significant growth in the coming years.

These factors have given rise to the need for sterilization equipment to prevent the further spread of infectious diseases. The expansion of pharmaceutical companies has also been a major factor in the market's growth. However, stringent regulatory standards for approval, production of these devices, and disadvantages of chemical agents used as chemical sterilants in some equipment, which may cause potential damage to the eyes and skin, have been restraining the market's growth.

Sterilization Equipment Market Trends

High-temperature Sterilization Equipment Dominates the Market

High-temperature equipment is the most widely used and the most dependable sterilization equipment. High-temperature sterilization is usually nontoxic to patients, staff, and the environment and is highly microbicidal. It also penetrates deep into the medical devices and is less costly than other sterilization equipment, thus making it cost-effective. These factors are responsible for the dominance of this segment in the market. High-temperature sterilization equipment is further sub-segmented into steam sterilization and dry sterilization.

The increasing number of several surgical procedures is boosting the high-temperature sterilization of surgical devices used in the process, which may drive the segment's growth. As per the American Joint Replacement Registry's Annual Report 2020, 1,897,050 primary and revision hip and knee arthroplasty procedures were performed between 2012 and 2019 in the United States. About 995,410 total knee arthroplasty and 625,097 total hip arthroplasty were also performed from 2012 to 2019 in the United States.

According to the American Society for Metabolic and Bariatric Surgery Statistics, around 256,000 surgeries and 252,000 surgeries were performed in 2019 and 2018, respectively, in the United States alone. These statistics show an increase in the number of bariatric surgeries, which is driving the growth of the overall market.

Moreover, the launch of new products in the segment may drive the market's growth. For instance, in May 2020, Esco launched Esco CelCulture CO2 Incubator with High Heat Sterilization (CCL-HHS). It has proven effective in killing resistant fungi, bacterial spore, and vegetative cells that may contaminate the workspace. Thus, such factors are expected to boost the segment's growth during the forecast period.

North America to Witness the Fastest Growth

North America experienced positive growth in the sterilization equipment market, and it is estimated to witness significant growth over the forecast period. The increasing risk of cross-contamination and hospital-acquired infections, rising number of surgeries, the presence of major market players, and growth in R&D procedures are expected to drive the market in the region. The United States is expected to dominate the North American market.

According to the '2020 HAI Progress Report Executive Summary' report published by the Centers for Disease Control and Prevention, approximately one in 31 US patients contract at least one hospital-acquired infection, highlighting the need for improvements in patient care practices in the country's healthcare facilities. Thus, hospital-acquired infections in the country are driving the need for proper hygiene maintenance and sterilization, including timely changing of hospital curtains.

In addition, the elderly population is prone to surgeries and is at higher risk of infections due to a weakened immune system. According to the World Ageing Report 2019, the country's elderly population is expected to increase from 53.340 million in 2019 to 83.813 million in 2050, thus increasing the incidence of infectious diseases and contributing to the market's growth.

The technological advancements in the field are also driving the market. For instance, in September 2020, Midmark Corporation launched the new Sterilizer Data Logger and the updated Midmark M3 Steam Sterilizer, bringing speed, simplicity, and compliance to instrument processing in dental practices in the United States.

Hence, there has been a surge in demand for medical devices and other instruments, increasing the demand for sterilization equipment.

Sterilization Equipment Industry Overview

The majority of sterilization equipment is being manufactured by global players. Market leaders with more funds for research and a better distribution system established their positions in the market. Major market players are Getinge AB, Fortive Corporation, Anderson Products, Cantel Medical, and Steris PLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Risks of Cross-transmission
    • 4.2.2 Increasing Number of Surgical Procedures
    • 4.2.3 Growth in Pharmaceutical and Biotechnology Industries
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Device
    • 4.3.2 Exposure to Chemicals in Equipments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Equipment
    • 5.1.1 High-temperature Sterilization
      • 5.1.1.1 Wet/Steam Sterilization
      • 5.1.1.2 Dry Sterilization
    • 5.1.2 Low-temperature Sterilization
      • 5.1.2.1 Ethylene Oxide (ETO)
      • 5.1.2.2 Hydrogen Peroxide
      • 5.1.2.3 Ozone
      • 5.1.2.4 Other Low-temperature Sterilization Equipment
    • 5.1.3 Filtration Sterilization
    • 5.1.4 Ionizing Radiation Sterilization
      • 5.1.4.1 E-beam Radiation Sterilization
      • 5.1.4.2 Gamma Sterilization
      • 5.1.4.3 Other Ionizing Radiation Sterilization Equipment
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Education and Research Institutes
    • 5.2.4 Food and Beverage Industries
    • 5.2.5 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Fortive Corporation (Advanced Sterilization Products)
    • 6.1.2 Anderson Products
    • 6.1.3 Metall Zug Group (Belimed)
    • 6.1.4 Cantel Medical
    • 6.1.5 Getinge AB
    • 6.1.6 Matachana Group
    • 6.1.7 MMM Group
    • 6.1.8 STERIS PLC
    • 6.1.9 Systec GmbH
    • 6.1.10 Stryker Corporation (TSO3 INC.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS